Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |